@article{26909210866c4ea6b8e63cae61c36be8,
title = "Clinical significance of AR-V567Es in prostate cancer-response",
author = "Tagawa, {Scott T.} and Antonarakis, {Emmanuel S.} and Ada Gjyrezi and Giuseppe Galletti and Paraskevi Giannakakou",
note = "Funding Information: S.T. Tagawa reports receiving commercial research grants from Sanofi, Janssen, Astellas, Pfizer, and Bayer, and is a consultant/advisory board member for Sanofi, Astellas, Bayer, and Janssen. E.S. Antonarakis holds ownership interest (including patents) in Qiagen. No potential conflicts of interest were disclosed by the other authors.",
year = "2019",
month = oct,
day = "1",
doi = "10.1158/1078-0432.CCR-19-1820",
language = "English (US)",
volume = "25",
pages = "6010--6011",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "19",
}